• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Fc 受体的内源性控制。

Inside-Out Control of Fc-Receptors.

机构信息

Department of Respiratory Medicine and Laboratory of Translational Immunology, University Medical Center Utrecht, Utrecht, Netherlands.

出版信息

Front Immunol. 2019 Mar 21;10:544. doi: 10.3389/fimmu.2019.00544. eCollection 2019.

DOI:10.3389/fimmu.2019.00544
PMID:30949181
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6437074/
Abstract

Receptors recognizing the Fc-part of immunoglobulins (FcR) are important in the engagement of phagocytes with opsonized micro-organisms, but they also play a major role in the pathogenesis of chronic inflammatory diseases. Different FcRs are specifically recognizing and binding the different classes of immunoglobulins, transmitting different signals into the cell. The function of IgG (FcγR's) and IgA (FcαR) recognizing receptors is controlled by cellular signals evoked by activation of heterologous receptors in a process generally referred to as inside-out control. This concept is clearly described for the regulation of integrin receptors. Inside-out control can be achieved at different levels by modulation of: (i) receptor affinity, (ii) receptor avidity/valency, (iii) interaction with signaling chains, (iv) interaction with other receptors and (v) localization in functionally different membrane domains. The inside-out control of FcRs is an interesting target for novel therapy by therapeutical antibodies as it can potentiate or decrease the functionality of the response to the antibodies depending on the mechanisms of the diseases they are applied for.

摘要

识别免疫球蛋白 Fc 部分的受体(FcR)在吞噬细胞与调理微生物的结合中很重要,但它们在慢性炎症性疾病的发病机制中也起着主要作用。不同的 FcR 特异性识别和结合不同类别的免疫球蛋白,向细胞内传递不同的信号。识别受体 IgG(FcγR)和 IgA(FcαR)的功能受细胞信号的控制,这些信号是由异源受体的激活引发的,这个过程通常被称为内向外控制。这个概念在整合素受体的调节中被清楚地描述。内向外控制可以通过调节以下几个方面来实现:(i)受体亲和力,(ii)受体亲合力/价数,(iii)与信号链的相互作用,(iv)与其他受体的相互作用,以及(v)在功能不同的膜域中的定位。FcR 的内向外控制是治疗性抗体的一个有趣的治疗靶点,因为它可以根据应用于疾病的机制增强或降低对抗体的反应功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e36/6437074/6564f2c41957/fimmu-10-00544-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e36/6437074/6564f2c41957/fimmu-10-00544-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7e36/6437074/6564f2c41957/fimmu-10-00544-g0001.jpg

相似文献

1
Inside-Out Control of Fc-Receptors.Fc 受体的内源性控制。
Front Immunol. 2019 Mar 21;10:544. doi: 10.3389/fimmu.2019.00544. eCollection 2019.
2
Fc receptor inside-out signaling and possible impact on antibody therapy.Fc 受体信号转导的研究进展及其对抗体治疗的影响
Immunol Rev. 2015 Nov;268(1):74-87. doi: 10.1111/imr.12332.
3
Understanding Fc Receptor Involvement in Inflammatory Diseases: From Mechanisms to New Therapeutic Tools.了解 Fc 受体在炎症性疾病中的作用:从机制到新的治疗工具。
Front Immunol. 2019 Apr 12;10:811. doi: 10.3389/fimmu.2019.00811. eCollection 2019.
4
Cross-talk between pathogen recognizing Toll-like receptors and immunoglobulin Fc receptors in immunity.病原体识别 Toll 样受体与免疫球蛋白 Fc 受体间的串扰在免疫中的作用。
Immunol Rev. 2015 Nov;268(1):311-27. doi: 10.1111/imr.12333.
5
The prospects for targeting FcR as a novel therapeutic strategy in rheumatoid arthritis.针对类风湿关节炎中 FcR 作为一种新型治疗策略的前景。
Biochem Pharmacol. 2021 Jan;183:114360. doi: 10.1016/j.bcp.2020.114360. Epub 2020 Dec 7.
6
Negative signaling in Fc receptor complexes.Fc受体复合物中的负向信号传导。
Adv Immunol. 2006;89:39-86. doi: 10.1016/S0065-2776(05)89002-9.
7
Functional and clinical consequences of Fc receptor polymorphic and copy number variants.Fc受体多态性和拷贝数变异的功能及临床后果
Clin Exp Immunol. 2009 Aug;157(2):244-54. doi: 10.1111/j.1365-2249.2009.03980.x.
8
Analyzing antibody-Fc-receptor interactions.分析抗体-Fc受体相互作用。
Methods Mol Biol. 2008;415:151-62. doi: 10.1007/978-1-59745-570-1_9.
9
Regulation of antibody production mediated by Fc gamma receptors, IgG binding factors, and IgG Fc-binding autoantibodies.由Fcγ受体、IgG结合因子和IgG Fc结合自身抗体介导的抗体产生的调节。
Crit Rev Biochem Mol Biol. 1992;27(3):191-225. doi: 10.3109/10409239209082563.
10
Fc receptors act as innate immune receptors during infection?Fc 受体在感染期间作为先天免疫受体发挥作用?
Front Immunol. 2023 Jul 26;14:1188497. doi: 10.3389/fimmu.2023.1188497. eCollection 2023.

引用本文的文献

1
Progress of immune checkpoint inhibitors in gastric cancer.免疫检查点抑制剂在胃癌中的研究进展
World J Gastrointest Oncol. 2025 Aug 15;17(8):109613. doi: 10.4251/wjgo.v17.i8.109613.
2
Advancing Antibody-Drug Conjugates: Precision Oncology Approaches for Breast and Pancreatic Cancers.推进抗体药物偶联物:乳腺癌和胰腺癌的精准肿瘤学方法
Cancers (Basel). 2025 May 27;17(11):1792. doi: 10.3390/cancers17111792.
3
FcγRIIB (CD32B) antibodies enhance immune responses through activating FcγRs.FcγRIIB(CD32B)抗体通过激活FcγRs增强免疫反应。

本文引用的文献

1
FcαRI Dynamics Are Regulated by GSK-3 and PKCζ During Cytokine Mediated Inside-Out Signaling.FcαRI 动力学受 GSK-3 和 PKCζ 在细胞因子介导的内向外信号转导过程中的调控。
Front Immunol. 2019 Jan 31;9:3191. doi: 10.3389/fimmu.2018.03191. eCollection 2018.
2
Mechanisms of inside-out signaling of the high-affinity IgG receptor FcγRI.高亲和力 IgG 受体 FcγRI 的内向外信号转导机制。
Sci Signal. 2018 Jul 24;11(540):eaaq0891. doi: 10.1126/scisignal.aaq0891.
3
Novel Concepts of Altered Immunoglobulin G Galactosylation in Autoimmune Diseases.
Clin Exp Immunol. 2025 Jan 21;219(1). doi: 10.1093/cei/uxaf015.
4
Neutrophils in cancer: from biology to therapy.癌症中的中性粒细胞:从生物学至治疗
Cell Mol Immunol. 2025 Jan;22(1):4-23. doi: 10.1038/s41423-024-01244-9. Epub 2024 Dec 9.
5
Ally, adversary, or arbitrator? The context-dependent role of eosinophils in vaccination for respiratory viruses and subsequent breakthrough infections.盟友、对手还是仲裁者?嗜酸性粒细胞在呼吸道病毒疫苗接种及其随后突破性感染中的上下文相关作用。
J Leukoc Biol. 2024 Jul 25;116(2):224-243. doi: 10.1093/jleuko/qiae010.
6
Universal chimeric Fc receptor T cells with appropriate affinity for IgG1 antibody exhibit optimal antitumor efficacy.对IgG1抗体具有适当亲和力的通用嵌合Fc受体T细胞表现出最佳的抗肿瘤功效。
Acta Pharm Sin B. 2023 May;13(5):2071-2085. doi: 10.1016/j.apsb.2023.02.004. Epub 2023 Feb 8.
7
Antibody Fc-chimerism and effector functions: When IgG takes advantage of IgA.抗体 Fc 嵌合体和效应功能:当 IgG 利用 IgA 时。
Front Immunol. 2023 Feb 2;14:1037033. doi: 10.3389/fimmu.2023.1037033. eCollection 2023.
8
Targeting the high affinity receptor, FcγRI, in autoimmune disease, neuropathy, and cancer.靶向自身免疫性疾病、神经病变和癌症中的高亲和力受体FcγRI。
Immunother Adv. 2022 May 28;2(1):ltac011. doi: 10.1093/immadv/ltac011. eCollection 2022.
9
Advances in Infectious Disease Vaccine Adjuvants.传染病疫苗佐剂的进展
Vaccines (Basel). 2022 Jul 13;10(7):1120. doi: 10.3390/vaccines10071120.
10
FcγRIIB controls antibody-mediated target cell depletion by ITIM-independent mechanisms.FcγRIIB 通过非 ITIM 依赖的机制控制抗体介导的靶细胞耗竭。
Cell Rep. 2022 Jul 19;40(3):111099. doi: 10.1016/j.celrep.2022.111099.
自身免疫性疾病中异常免疫球蛋白 G 半乳糖基化的新概念。
Front Immunol. 2018 Mar 19;9:553. doi: 10.3389/fimmu.2018.00553. eCollection 2018.
4
Antibody receptors steal the sweet spotlight.抗体受体偷走了甜蜜的聚光灯。
J Biol Chem. 2018 Mar 9;293(10):3490-3491. doi: 10.1074/jbc.H118.001955.
5
New revelations from an old receptor: Immunoregulatory functions of the inhibitory Fc gamma receptor, FcγRIIB (CD32B).旧受体的新发现:抑制性Fcγ受体FcγRIIB(CD32B)的免疫调节功能
J Leukoc Biol. 2018 Feb 6. doi: 10.1002/JLB.2MIR0917-354R.
6
FcγRIIIB stimulation promotes β1 integrin activation in human neutrophils.FcγRIIIB刺激可促进人中性粒细胞中的β1整合素激活。
J Leukoc Biol. 2005 May;77(5):787-799. doi: 10.1189/jlb.0504310.
7
Restricted processing of CD16a/Fc γ receptor IIIa -glycans from primary human NK cells impacts structure and function.原发性人自然杀伤细胞中 CD16a/Fcγ 受体 IIIa-聚糖的受限加工影响结构和功能。
J Biol Chem. 2018 Mar 9;293(10):3477-3489. doi: 10.1074/jbc.RA117.001207. Epub 2018 Jan 12.
8
Neutrophil CD16b crosslinking induces lipid raft-mediated activation of SHP-2 and affects cytokine expression and retarded neutrophil apoptosis.中性粒细胞 CD16b 交联诱导脂筏介导的 SHP-2 活化,并影响细胞因子表达和抑制中性粒细胞凋亡。
Exp Cell Res. 2018 Jan 1;362(1):121-131. doi: 10.1016/j.yexcr.2017.11.009. Epub 2017 Nov 11.
9
Current progress in innovative engineered antibodies.创新工程抗体的最新进展。
Protein Cell. 2018 Jan;9(1):86-120. doi: 10.1007/s13238-017-0457-8. Epub 2017 Aug 18.
10
Signaling by Antibodies: Recent Progress.抗体信号传导:最新进展
Annu Rev Immunol. 2017 Apr 26;35:285-311. doi: 10.1146/annurev-immunol-051116-052433.